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IMPACT OF OXYGEN CONTENT ON CHARACTERISTICS OF
MESENCHYMAL STEM CELLS ISOLATED FROM WHARTON'S JELLY
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Santé, Vandoeuvre-lès-Nancy, France; 2 Lorraine Univ., 54000 Nancy,
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Purpose: Mesenchymal stem cells from human Wharton's jelly (WJ-MSC)
represent an abundant and interesting source of stem cells for applications
in tissue engineering. Their fetal origin confers speciﬁc characteristics
compared to mesenchymal stem cells isolated from human bone marrow
(BM-MSC). The aim of this work is to carry out an accurate characterization
of WJ-MSC during their in vitro expansion which is a need for their use for
research and clinical applications to tissue and cell engineering. We focuse
on the impact of oxygen content during monolayer expansion.
Methods: WJ-MSC are isolated from umbilical cords by a non-enzymatic
method. Culture is performed until the seventh passage in normoxia (21%
of O2) or hypoxia (5% of O2). Different parameters are evaluated after P1, P3,
P5 and P7. Colony-forming units-ﬁbroblast (CFU-F) assays is performed to
evaluate the clonal expansion capacity of WJ-MSC. The proliferation is
evaluated by the population doubling time and the telomerase activity.
HLA-G molecule expression, related to immunomodulatory properties of
these cells, is assessed by qRT-PCR and also by ﬂow cytometry. After an
immunophenotype analysis of WJ-MSC by ﬂow cytometry, MSC are
directed towards the three ways of mesodermic differentiation which are
chondrogenesis, osteogenesis and adipogenesis. Finally, pluripotent stem
cell markers expression including Oct4, Sox2 and Nanog is performed by
qRT-PCR during expansion.
Results: Regardless of the passage, the low oxygen tension increases
proliferation capacity, signiﬁcantly decreases population doubling time of
WJ-MSC, and seems to increase HLA-G expression. Telomerase activity is
very low compared to HeLa cells (positive control) and no signiﬁcant
difference is observed between normoxia and hypoxia conditions. During
expansion, this activity is signiﬁcantly more important in P3 and P5 than in
P7 (p<0,001). Finally, according to histological labeling, hypoxia seems to
inhibit osteogenic differentiation and seems to be a contributing factor on
chondrogenesis. Regardless of culture conditions, adipogenic differentia-
tion of WJ-MSC seems difﬁcult to obtain.
Conclusions: Hypoxic conditions during WJ-MSC monolayer expansion
inﬂuence cell proliferation capacity and mesodermic differentiation
potential. Although WJ-MSC telomerase activity is detected, it remains
relatively low compared to positive control and decreases during expan-
ion. According to the use of WJ-MSC to tissue or cell engineering, it will be
necessary to adapt culture conditions and in particular the oxygen content.
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DIFFERENTIATION OF HUMAN ADULT MESENCHYMAL STEM CELLS IN
CHONDROCYTES FOR CARTILAGE ENGINEERING
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Purpose: Because articular cartilage has a poor intrinsic regeneration
ability, Autologous Chondrocytes Implantation (ACI) has emerged as an
alternative therapeutic strategy in cartilage healing after trauma or aged
related degeneration. The ﬁrst generation of ACI is limited by the dedif-
ferentiation process occurring during chondrocytes expansion, chon-
drocytes volume density being only 2%. In this context and to obtain
biological substitutes closely similar to hyaline cartilage, some upgrading
ACI are developed, using the therapeutic potential of mesenchymal stem
cells (MSCs). Thus, chondrocytes could be obtained from MSCs by chon-
drogenesis induction. Today, adult MSCs provide new hopes for theregenerative medicine, even if it seems that for one clinical application, all
MSCs are not suitable. In this study, we have developed a process allowing
MSCs from bone marrow to differentiate in chondrocytes able to synthe-
size matrix components characteristic of the hyaline cartilage.
Methods: Multipotent and immunophenotypically characterized MSCs
from bone marrow were ampliﬁed in monolayer cultures until 5 passages.
The differentiation step used an innovative approach combining 3D-
culture in type I collagen sponges, low oxygen tension and chondrogenic
factors (BMP-2 and TGF-ß1), their impact being sustained and improved by
RNA interference targeting two molecules whose expression is increased
in osteoarthritis.
Results: In this study, we have differentiated MSCs from bone marrow in
chondrocytes and these innovating results have led to an international
patent submission (patent request NPCT/FR2011/052198). Indeed, we
demonstrated that when we treated scaffold colonized by MSCs during 14
days in hypoxia, with chondrogenic factors and two siRNAs, we obtain
a chondrocyte phenotype, evaluated by 16 genes analysis (including
Integrin-ß1, SOX9, HIF-1a, HIF-2a, osteogenic markers and a new cartilage
marker), closely similar to the one observed in chondrocytes from healthy
cartilage. Our treatment allowed the increase of cartilage speciﬁc markers
such as type II collagen and aggrecan and the decrease of non speciﬁc
markers such as type III and type I collagens.
Conclusions: This work gives new insights in the molecular regulation
involved during the differentiation of MSCs in mature chondrocytes. This
approach could be better and could give more satisfactory results than
those observed with ACI. Preclinical-trials are planned in horses which
constitute an inescapable step to develop in the future, novel cell therapies
of articular defects in human.
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EFFECT OF ADIPOSE DERIVED STEM CELLS INJECTION IN AN
EXPERIMENTAL OSTEOARTHRITIS MODEL
G. Desando, B. Grigolo, C. Cavallo, C. Manferdini, G. Lisignoli, L. Martini,
F. Veronesi, A. Parrilli, M. Fini, R. Giardino, A. Facchini. Istituto Ortopedico
Rizzoli, Bologna, Italy
Purpose: The opportunity to enlarge the indications of autologous cell
transplantation to the treatment of degenerative changes in osteoarthritis
(OA) patients is very intriguing. Some interesting results have been
obtained by our Group by the implant of mesenchymal stem cells (MSCs) in
a rabbitmodel ofOA. Adiposederived stromal cells (ADSCs) are an attractive
source because of their plasticity, immuno-modulatory anti-ﬁbrotic prop-
erties, which render them appealing in the ﬁeld of cartilage tissue engi-
neering. For this reason, the aim of our study was to assess the efﬁcacy of
ADSC intra-articular injections in an experimental OA rabbit model.
Methods: 42 Adult male New Zealand rabbits were used. European and
Italian laws on animal experimentation were strictly followed throughout
the study. Rabbit knee joints were bilaterally subjected to Anterior Cruciate
Ligament Transection (ACLT) to surgically induce OA. After 8 weeks from
ACLT, the injured knees were treated with autologous 2.0x106 and 6.0x106
ADSC suspended in 4 % RSA (experimental group) or 4% RSA (control
group) by intra-articular injections. CM DiI labeling was used to evaluate
ADSC local biodistribution in vivo. Animals were sacriﬁed by means of an
intravenous lethal injection of Tanax at 2 and 4 months. Both femurs,
menisci and synovia were explanted and used to perform morphological
histomorphometric, histological, immunohistochemical and micro-CT
evaluations. Laverty's and Kraus’ Modiﬁed Mankin scoring systems were
used for histological assessment of osteoarthritis.
Results: Labeled ADSC were detected in the synovial tissue (in particular in
the synovial lining) and in the medial meniscus along all the specimen
thickness.Nocell engraftmentwasobserved in thearticularcartilage fromthe
medial and lateral femoral condyle and tibial plateau. At 8 weeks form ACLT,
structural alteration, superﬁcial ﬁbrillation, proteoglycan depletion, cluster
formation were observed in the cartilage of rabbit medial femoral condyles.
The treatment with both concentration of ADSC leaded, starting already at 2
months follow-up, to the regeneration of cartilage tissue with hyaline-like
aspect with smooth surface and high presence of proteoglycan component.
These featuresweremore evident in the joints that received the lowest ADSC
concentration with some differences between lateral and medial condyles.
